Tick-borne encephalitis future or investigational new therapies
|
Tick-borne encephalitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tick-borne encephalitis future or investigational new therapies On the Web |
|
American Roentgen Ray Society Images of Tick-borne encephalitis future or investigational new therapies |
|
FDA on Tick-borne encephalitis future or investigational new therapies |
|
CDC on Tick-borne encephalitis future or investigational new therapies |
|
Tick-borne encephalitis future or investigational new therapies in the news |
|
Blogs on Tick-borne encephalitis future or investigational new therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ilan Dock, B.S.
Overview
An investigational new therapy, Phosphrenyl treatment, similar to interferon treatment for Hepatitis C, is the mainstay investigational treatment in treating tick-borne encephalitis. Antibiotic therapies are useful as many disease vectors responsible for transmission of tick-borne encephalitis also carry many other tick-borne diseases. An antibiotic therapy may be helpful in anticipating any potential tick-borne co-infections.
Future and Investigational New Therapies
- The mainstay investigational therapy for tick-borne encephalitis is Phosphrenyl treatment.
- Phosphrenyl treatment including both a therapeutic and prophylactic agent for TBE
- Antibiotic treatment may be necessary for potential tick-borne, co-infections.[1][2][3]
References
- ↑ Streptomycin--an activator of persisting tick-borne encephalitis virus.Malenko G, Pogodina V, Karmysheva V (1984). "[Streptomycin--an activator of persisting tick-borne encephalitis virus]". Vopr Virusol. 29 (2): 217–23. PMID 6730440. Unknown parameter
|month=ignored (help) - ↑ Experimental phytotherapy of tick-borne encephalitis.Fokina G, Frolova T, Roĭkhel' V, Pogodina V (1991). "[Experimental phytotherapy of tick-borne encephalitis]". Vopr Virusol. 36 (1): 18–21. PMID 1858353. Unknown parameter
|month=ignored (help) - ↑ Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis.Ozherelkov S, Timofeev A, Novikova G, Deeva A, Narovlianskiĭ A, Sanin A, Pronin A (2000). "[Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis]". Vopr Virusol. 45 (1): 33–7. PMID 10695042. Unknown parameter
|month=ignored (help)